Tandem Diabetes Care (TNDM) - רווח נקי למניה (EPS TTM)

Tandem Diabetes Care relies on stable demand, with a seasonal sales peak occurring at year-end. The GURU.Markets platform displays a chart showing the 12-month rolling earnings per share history, where the -0.73 metric confirms the current level. Growth is driven by the integration of t:slim X2 pumps with glucose sensors and a strong team of interface developers.
TNDM (Tandem Diabetes): פילוחים אנליטיים ודוחות לפי אינדיקטורים

For an investor assessing the financial stability of an issuer, the trailing twelve-month net income per share serves as a key metric for capital allocation efficiency, calculated as the ratio of total income to the total number of securities. In the context of Tandem Diabetes Care (TNDM), the trend of this indicator reflects the ability of the "razor-and-blade" model to convert Mobi pump and consumable sales into actual shareholder returns.